To learn more, please visit www.reprievetrial.org.

GSK (GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer (PFE) and Shionogi (SGIOY) as ...

Older adults with HIV are at significantly higher risk for cutaneous malignancies when compared with younger patients with HIV.

Toxoplasmosis and MDD were among several preexisting comorbidities associated with the development of neurocognitive disorders in patients with HIV infection.

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...

In 1985, the first year that a test for HIV became available, Mike Hellman tested positive. It was a terrifying diagnosis at ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Bridgette J. Picou, LVN, ACLPN, presented research on the lived experiences of women living with HIV and going through ...

Let’s take your partner’s HIV status out of the equation for a moment. You’re looking at a person who has a concerning temper, refuses to admit faults (and, therefore, probably refuses to work on them ...

HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...